Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer

Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer

NCT00452985 ·Status: COMPLETED

Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer

NCT04257786 ·Status: UNKNOWN ·Phase: NA

Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer

NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2

Study of DP303c Injection in Patients With Advanced Ovarian Cancer

NCT04828616 ·Status: UNKNOWN ·Phase: PHASE2

The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study

NCT05265117 ·Status: UNKNOWN

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

NCT00443196 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

NCT03491033 ·Status: COMPLETED

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

NCT00582205 ·Status: TERMINATED ·Phase: PHASE2

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01074411 ·Status: COMPLETED ·Phase: PHASE1

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

NCT02728622 ·Status: COMPLETED ·Phase: PHASE3

Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer

NCT00005051 ·Status: COMPLETED ·Phase: PHASE2

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

NCT03949283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An INternational Frontline Ovarian Cancer Real World Management Study

NCT04460768 ·Status: COMPLETED

Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00055614 ·Status: COMPLETED ·Phase: PHASE1

Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3

Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00066456 ·Status: COMPLETED ·Phase: PHASE1

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer

NCT00093496 ·Status: COMPLETED ·Phase: PHASE2

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

NCT05415709 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer

NCT03180177 ·Status: UNKNOWN ·Phase: PHASE3

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00897039 ·Status: UNKNOWN

Intra-peritoneal Chemotherapy in Ovarian Cancer

NCT02861872 ·Status: UNKNOWN

Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer

NCT00003732 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

NCT01366183 ·Status: UNKNOWN

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814 ·Status: COMPLETED

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

NCT00402935 ·Status: WITHDRAWN